Answers are grounded in this paper and cite their sources.
A pragmatic approach to the discovery of new SARS-COV-2 Mpro inhibitors by combining generative chemistry and computational chemistry approaches.
No takes yet. Share an insight, caveat, or question.
Hazemann et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: